Toggle Nav
Close
  • Menu
  • Setting

Mavelertinib

Catalog No.
BA6334
Mavelertinib is a selective, orally effective and irreversible tyrosine kinase inhibitor with values of 5, 4, 12 and 3 nM for Del, L858R and double mutant T790M/L858R and T790M/Del, respectively.
Grouped product items
SizePriceStock Qty
1mL(10 mM in DMSO)
$207.00
Ship with 10-15 days
1mg
$90.00
Ship with 10-15 days
5mg
$189.00
Ship with 10-15 days
10mg
$302.00
Ship with 10-15 days
25mg
$544.00
Ship with 10-15 days
50mg
$816.00
Ship with 10-15 days
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Mavelertinib is a selective, orally potent and irreversible tyrosine kinase inhibitor with values of 5, 4, 12, and 3 nM for Del, L858R, and the double mutants T790M/L858R and T790M/Del, respectively.Mavelertinib is available for non-small cell lung cancer (NSCLC).

Chemical Properties

Physical AppearanceA solid
Storage-20°C
M.Wt415.42
Cas No.1776112-90-3
FormulaC18H22FN9O2
SynonymsPF-06747775
Shipping ConditionSmall Molecules with Blue Ice, Modified Nucleotides with Dry Ice.
General tips We do not recommend long-term storage for the solution, please use it up soon.